Protein S100-A4 (S100A4) was associated with a reduced risk of overall LC in the MR analysis and a decreased risk of LUSC in the population analysis, aligning with Smith-Byrne et al.’s reported protective effect (OR = 0.814) [61]. Here, S100A4 is linked to laryngotracheoesophageal cleft.